Page 265 - Tata_Chemicals_yearly-reports-2021-22
P. 265

01   INTEGRATED      73  STATUTORY      178  FINANCIAL
                  REPORT
                                      REPORTS
                                                          STATEMENTS
                                                          Consolidated


            Consolidated Statement of Profit and Loss for the year ended March 31, 2022
                                                                                                        ` in crore
                                                                                          Year ended   Year ended
                                                                                 Note   March 31, 2022  March 31, 2021
             I.  Income
                 a)   Revenue from operations                                     27       12,622.12    10,199.80
                 b)   Other income                                                28         255.98       234.42
                 Total Income (a + b)                                                      12,878.10    10,434.22
             II.  Expenses
                 a)   Cost of materials consumed                                            2,423.91     2,081.16
                 b)   Purchases of stock-in-trade                                            335.96       322.85
                 c)   Changes in inventories of finished goods, work-in-progress and stock-in-trade  29  (122.56)  (7.09)
                 d)   Employee benefits expense                                   30        1,540.00     1,399.74
                 e)   Finance costs                                               31         302.84       367.37
                 f)   Depreciation and amortisation expense                       32         806.12       759.32
                 g)   Other expenses                                              33        6,140.18     4,902.50
                 Total expenses (a to g)                                                   11,426.45    9,825.85
             III.   Profit before exceptional items, share of profit of joint ventures and associate and tax (I-II)  1,451.65  608.37
             IV.   Exceptional item (net)                                         34         (11.04)         -
             V.   Profit before share of profit of joint ventures and associate and tax (III-IV)  1,440.61  608.37
             VI.   Share of profit of joint ventures and associate (net of tax)  9(a),       226.02        25.62
                                                                                 9(b)
             VII.   Profit before tax (V+VI)                                                1,666.63     633.99
             VIII.  Tax expense
                 (a)   Current tax                                                35         274.33       225.79
                 (b)   Deferred tax                                               35          (7.85)      (28.02)
                 Total tax expense (a+b)                                                     266.48      197.77
             IX.   Profit for the year from continuing operations (VII-VIII)                1,400.15     436.22
             X.   Exceptional gain from discontinued operations (net)            36(i)         28.37          -
             XI.   Share of loss of joint ventures (net of tax)                  9(a),        (10.08)         -
                                                                                 36(ii)
             XII.   Tax expense of discontinued operations                       36(i)         13.31          -
             XIII.   Profit for the year from discontinued operations (X+XI-XII)               4.98           -
             XIV.  Profit for the year (IX+XIII)                                             1,405.13     436.22
             XV.   Other comprehensive income (net of tax) (‘OCI’) - gain/(loss)
                 A    (i)   Items that will not be reclassified to the Consolidated Statement of Profit and Loss
                         -   Changes in fair value of investments in equities carried at fair value through OCI  1,690.83  1,188.93
                         -   Remeasurement of defined employee benefit plans (note 40)       396.57       175.12
                     (ii)   Income tax relating to items that will not be reclassified to the Consolidated Statement of Profit and Loss  207.88  215.82
                     (iii)   Share of other comprehensive income in joint ventures (net of tax)  109.30   167.29
                 B   (i)   Items that will be reclassified to the Consolidated Statement of Profit and Loss
                         -   Effective portion of gain/(loss) on cash flow hedges           1,034.28      291.06
                         -   Changes in foreign currency translation reserve                 128.62      (178.47)
                     (ii)   Income tax relating to items that will be reclassified to the Consolidated Statement of Profit and Loss  196.98  8.63
                     (iii)   Share of other comprehensive income in joint ventures (net of tax)  4.72     (3.12)
                 Total other comprehensive income - gain (net of tax) (A (i-ii+iii) +B (i-ii+iii))  2,959.46  1,416.36
             XVI.  Total comprehensive income for the year (XIV+XV)                         4,364.59    1,852.58
             XVII.  Profit for the year from continuing operations (IX)
                 Attributable to:
                 (i)   Equity shareholders of the Company                                   1,252.64      256.37
                 (ii)   Non-controlling interests                                            147.51       179.85
                                                                                            1,400.15     436.22
             XVIII.  Profit for the year from discontinued operations (XIII)
                 Attributable to:
                 (i)   Equity shareholders of the Company                                      4.98          -
                 (ii)   Non-controlling interests                                                -           -
                                                                                              4.98           -
             XIX.  Profit for the year (XIV)
                 Attributable to:
                 (i)   Equity shareholders of the Company                                   1,257.62      256.37
                 (ii)   Non-controlling interests                                            147.51       179.85
                                                                                            1,405.13     436.22
             XX.   Other comprehensive income - gain/(loss) (net of tax) (XV)
                 Attributable to:
                 (i)   Equity shareholders of the Company                                   2,959.78     1,415.66
                 (ii)   Non-controlling interests                                             (0.32)       0.70
                                                                                            2,959.46    1,416.36
             XXI.  Total comprehensive income for the year (XVI)
                 Attributable to:
                 (i)   Equity shareholders of the Company                                   4,217.40     1,672.03
                 (ii)   Non-controlling interests                                            147.19       180.55
                                                                                            4,364.59    1,852.58
             XXII.  Earnings per share for continuing operations (in `)
                 -    Basic and Diluted                                           37          49.17        10.06
             XXIII.  Earnings per share for discontinued operations (in `)
                 -   Basic and Diluted                                            37           0.20          -
             XXIV.  Earnings per share for continuing and discontinued operations (in `)
                 -   Basic and Diluted                                            37          49.37        10.06
            Notes 1 to 50 are integral part of these Consolidated Financial Statements
            As per our report of even date attached              For and on behalf of the Board
            For B S R & Co. LLP                                  N. Chandrasekaran     Chairman
            Chartered Accountants                                (DIN: 00121863)       Director
                                                                 Padmini Khare Kaicker
            Firm’s Registration No: 101248W/W - 100022           (DIN: 00296388)
                                                                 R. Mukundan           Managing Director and CEO
            Vijay Mathur                                         (DIN: 00778253)
            Partner                                              Nandakumar S. Tirumalai   Chief Financial Officer
                                                                 (ICAI M. No.: 203896)
            Membership No. 046476                                Rajiv Chandan         General Counsel & Company Secretary
            Mumbai, April 29, 2022                               (ICSI M. No.: FCS 4312)
                                                                                                           263
   260   261   262   263   264   265   266   267   268   269   270